can retatrutide affect sleep side effects: what the trials show and how to manage them Wegovy and Sleep: Causes, Insomnia

Bremner JD, Moazzami K, Wittbrodt MT, Nye JA, Lima BB, Gillespie CF, Rapaport MH, Pearce BD, Shah AJ, Vaccarino V

Glucagon-like peptide-1 agonists are a class of medications that mimic the natural GLP-1 hormone to manage type 2 diabetes and obesity

By protecting immune cells from oxidative damage, glutathione supports their optimal function and enhances immune responsiveness

In a glycemic control trial evaluating a dose comparable to the 9 mg dose and the 25 mg semaglutide tablet doses in patients with T2D, 1.3% and 1.9% of patients in the 9 mg and 25 mg semaglutide group, respectively, reported moderate-severe non-proliferative diabetic retinopathy events, and 0% and 0.4% reported proliferative retinopathy events, respectively